Martini LG - Search Results

1

Developing paediatric medicines: identifying the needs and recognizing the challenges.

Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. Ernest TB, et al. Among authors: martini lg. J Pharm Pharmacol. 2007 Aug;59(8):1043-55. doi: 10.1211/jpp.59.8.0001. J Pharm Pharmacol. 2007. PMID: 17725846 Review.

2

The use of hypromellose in oral drug delivery.

Li CL, Martini LG, Ford JL, Roberts M. Li CL, et al. Among authors: martini lg. J Pharm Pharmacol. 2005 May;57(5):533-46. doi: 10.1211/0022357055957. J Pharm Pharmacol. 2005. PMID: 15901342 Review.

3

Influence of ethanol on aspirin release from hypromellose matrices.

Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG, Crowley PJ. Roberts M, et al. Among authors: martini lg. Int J Pharm. 2007 Mar 6;332(1-2):31-7. doi: 10.1016/j.ijpharm.2006.09.055. Epub 2006 Oct 6. Int J Pharm. 2007. PMID: 17084050

4

The influence of gamma irradiation on the physicochemical properties of a novel triblock copolymer of epsilon-caprolactone and ethylene oxide.

Martini L, Collett JH, Attwood D. Martini L, et al. J Pharm Pharmacol. 1997 Jun;49(6):601-5. doi: 10.1111/j.2042-7158.1997.tb06852.x. J Pharm Pharmacol. 1997. PMID: 9330199

5

Effects of oxygen plasma treatment on the surface wettability and dissolution of furosemide compacts.

Naseem A, Olliff CJ, Martini LG, Lloyd AW. Naseem A, et al. Among authors: martini lg. J Pharm Pharmacol. 2003 Nov;55(11):1473-8. doi: 10.1211/0022357022070. J Pharm Pharmacol. 2003. PMID: 14713357

6

Solubility parameter and oral absorption.

Martini LG, Avontuur P, George A, Willson RJ, Crowley PJ. Martini LG, et al. Eur J Pharm Biopharm. 1999 Nov;48(3):259-63. doi: 10.1016/s0939-6411(99)00055-7. Eur J Pharm Biopharm. 1999. PMID: 10612038

7

The use of a hydrophobic matrix for the sustained release of a highly water soluble drug.

Martini LG, Coles M, Gravell K, Stephenson S, Thomson CM. Martini LG, et al. Drug Dev Ind Pharm. 2000 Jan;26(1):79-83. doi: 10.1081/ddc-100100330. Drug Dev Ind Pharm. 2000. PMID: 10677813

8

The release of 5-fluorouracil from microspheres of poly(epsilon-caprolactone-co-ethylene oxide).

Martini LG, Collett JH, Attwood D. Martini LG, et al. Drug Dev Ind Pharm. 2000 Jan;26(1):7-12. doi: 10.1081/ddc-100100321. Drug Dev Ind Pharm. 2000. PMID: 10677804

9

Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads.

Stops F, Fell JT, Collett JH, Martini LG. Stops F, et al. Among authors: martini lg. Int J Pharm. 2008 Feb 28;350(1-2):301-11. doi: 10.1016/j.ijpharm.2007.09.009. Epub 2007 Sep 14. Int J Pharm. 2008. PMID: 17964096

10

The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state.

Stops F, Fell JT, Collett JH, Martini LG, Sharma HL, Smith AM. Stops F, et al. Among authors: martini lg. Int J Pharm. 2006 Feb 3;308(1-2):8-13. doi: 10.1016/j.ijpharm.2005.09.036. Epub 2005 Dec 9. Int J Pharm. 2006. PMID: 16338108 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page